Blood Flow Measurement Devices Market

Views:
 
Category: Entertainment
     
 

Presentation Description

According to research report the blood flow measurement devices market is projected to reach USD 533.0 Million by 2021 from USD 343.6 Million in 2016, growing at a CAGR of 9.2%

Comments

Presentation Transcript

slide 1:

Blood Flow Measurement Devices Market – Business Intelligent and Top Key Players According to research report the blood flow measurement devices market is projected to reach USD 533.0 Million by 2021 from USD 343.6 Million in 2016 growing at a CAGR of 9.2 Blood flow measurement devices are used to measure the volume rate of blood flow which helps physicians to maintain equilibrium between blood supply and demand of tissue oxygen of patients. The measurement of blood flow helps in identifying blockages in the blood vessels and testing artificial blood vessels during organ transplantation among others. These devices are imperative for diagnosing various clinical vascular conditions such as arterial occlusion peripheral vascular diseases including diabetes micro- and macro-vascular complications. The devices also find applications in skin testing cerebral blood flow measurement and burn assessment. The major market players in the blood flow measurement devices market include Medistim ASA Norway Transonic Systems Inc. U.S. Cook Medical Inc. U.S. Moor Instruments Ltd. U.K. ADInstruments Australia SONOTEC Ultraschallsensorik Halle GmbH Germany Deltex Medical Group plc U.K. Atys Medical France Compumedics Ltd. Australia Perimed AB Sweden and BIOPAC Systems Inc. U.S.. Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.aspid243081818 Product launches product enhancements and product extensions accounted for 42 of the total number of strategic developments undertaken by market players during 2013 to 2017 Players adopted this strategy to develop commercialize and expand their product services portfolio so as to strengthen their customer base and provide better access to their clients. The key players that adopted this strategy are Medistim ASA Norway SONOTEC Ultraschallsensorik Halle GmbH Germany Cook Medical Inc. U.S. and ADInstruments Australia. Collaborations agreements contracts joint ventures and partnerships accounted for 30 of the total key growth strategies adopted by the players in this market during 2013 to 2016. This strategy was adopted to strengthen their presence in various geographies. The key players who adopted this strategy include Compumedics Ltd. Australia Medistim ASA Norway Transonic System Inc. U.S. ADInstruments Australia Deltex Medical Group PLC U.K. BIOPAC Systems Inc. U.S. and Oxford Optronix Ltd. U.K.. Few of the instances of the strategies followed by the players have been discussed below:  In February 2017 Medistim ASA established its subsidiary—Medistim Spain S.L. with sales representatives in Madrid and Barcelona. With this expansion the company aims to support its customers and upgrade its MiraQ installations with combined TTFM and imaging technology.  In October 2016 SONOTEC introduced its contactless SONOFLOW sensors to reduce contamination by sensitive fluids. They are made of materials like aluminum stainless steel and plastic which are easy to use and best suited for severe hygienic settings.  In April 2016 ADInstruments entered into a partnership with Data Sciences International DSI U.S. to integrate DSI’s PhysioTelTM implantable telemetry platform with ADI’s acquisition and analysis software—LabChart. ADI will fill in as a selective distributor of DSI instruments. The company aims to provide best quality solutions to their customers with this integration.

slide 2:

Contact: Mr. Shelly Singh MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook IL 60062 USA : 1-888-600-6441 newslettermarketsandmarkets.com

authorStream Live Help